Procter & Gamble Health Ltd

₹ None%

- close price

About

P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.^[1]

Key Points

Strong Brand Portfolio
Company is one the India’s largest VMS companies, manufacturing and marketing vitamins, minerals and supplements. It has a strong portfolio of various pharma brands such as Evion, Neurobion, Seven seas, Nasivion, Polybion, Cosome and Livogen. ^[1]

Website BSE NSE

Market Cap ₹ Cr.
Current Price ₹
High / Low ₹ /
Stock P/E
Book Value ₹
Dividend Yield %
ROCE %
ROE %
Face Value ₹

Add ratio to table

Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE SmallCap BSE Allcap BSE 250 SmallCap Index BSE 400 MidSmallCap Index

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores




Operating Profit
OPM %

Interest
Depreciation
Profit before tax
Tax %

EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores




Operating Profit
OPM %

Interest
Depreciation
Profit before tax
Tax %

EPS in Rs
Dividend Payout %

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Figures in Rs. Crores


Equity Capital
Reserves


Total Liabilities

CWIP
Investments

Total Assets

Cash Flows

Figures in Rs. Crores





Net Cash Flow

Ratios

Figures in Rs. Crores


Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Shareholding Pattern

Numbers in percentages

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%
	6.05%	6.33%	6.72%	7.15%	7.38%	7.60%	6.24%	6.39%	6.61%	7.01%	6.86%	6.99%
	12.62%	12.44%	12.31%	12.29%	12.30%	12.66%	13.72%	14.56%	14.84%	14.71%	14.21%	14.15%
	29.51%	29.41%	29.14%	28.74%	28.50%	27.92%	28.22%	27.24%	26.74%	26.47%	27.11%	27.03%
No. of Shareholders	65,148	63,831	61,030	58,856	57,919	56,730	56,778	55,923	54,792	53,736	53,993	52,478

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Jun 2025
	51.80%	51.80%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%
	2.28%	3.66%	4.24%	4.62%	6.71%	6.57%	6.72%	6.24%	6.86%	6.99%
	10.07%	9.59%	7.42%	10.39%	11.48%	7.91%	12.31%	13.72%	14.21%	14.15%
	35.85%	34.95%	36.53%	33.17%	30.00%	33.71%	29.14%	28.22%	27.11%	27.03%
No. of Shareholders	31,699	28,556	32,142	45,514	53,076	66,289	61,030	56,778	53,993	52,478

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Procter & Gamble Health Ltd

Procter & Gamble Health Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings

Concalls